Characterizing ofatumumab patient onboarding and utilization in relapsing multiple sclerosis using msgo: 3rdinterim analysis of part i of the EAFToS Study

Authors
Category Primary study
ConferenceACTRIMS Forum 2025
Year 2025
This article has no abstract
Epistemonikos ID: 39d4c8631dff832ff78b5447ebc9491d6482fc60
First added on: Jan 31, 2026